This content is from: Premium Hedge Funds Go Bottom Fishing in Biopharma Over the past few weeks, four different life sciences hedge funds have taken stakes of at least 5 percent in more than a half dozen stocks. By Stephen Taub October 04, 2022
This content is from: Premium Storm Clouds on the Horizon For stock-oriented hedge fund investors, this will definitely be a September to remember — for all the wrong reasons. By Stephen Taub September 30, 2022
This content is from: Portfolio Institutional Investors and Hedge Funds Are Selling Their Stocks. Retail Is Buying. Institutional investors rotated out of stocks in all sectors, including energy, financials, healthcare, technology, basic materials, consumer goods, and real estate. By Jessica Hamlin September 19, 2022
This content is from: Premium These Are the Most Popular Hedge Fund Stocks A new company tops SEI Novus’s exhaustive ranking of the 15 stocks with the most hedge fund managers. By Stephen Taub August 24, 2022
This content is from: Portfolio Hedge Funds Won’t Want to Hear This Two big pension funds virtually match the performance of a popular benchmark, while Princeton’s and Harvard’s hedge fund allocations beat the index, according to MPI research. By Julie Segal August 12, 2022
This content is from: Premium Life Sciences Funds Show Some Signs of Health Many funds have erased a big slice of their early-year losses but still have a long way to go to break even. By Stephen Taub September 15, 2022
